[DP-Neuralgen. Clinical trials in patients with the radicular syndrome].
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001416:Back Pain / Q000188:drug therapy* / Q000209:etiology; D002110:Caffeine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010615:Phenacetin / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use
D000700:Analgesics; D004338:Drug Combinations; C049310:aspirin, caffeine, codeine drug combination; D002110:Caffeine; C037143:DP-neuralgen; D010615:Phenacetin; D001241:Aspirin; D011431:Dextropropoxyphene; D003061:Codeine; D010634:Phenobarbital
DP-Neuralgén. Klinické skúsky u pacientov s radikulárnym syndrómom.